ABSTRACT: Emerging drug technologies have the ability torevolutionize the healthcare sector.These include 3D printing, nanotechnology, artificial intelligence (AI) and machine learning, and pharmacogenomics etc. One of the most promising technologies is 3D printing, which enables the production of tailored dosage forms, regenerative therapies, and implantable medical devices. 3D printing allows for the creation of pharmaceutical assets that can be designed in different forms, sizes, shapes, and release mechanisms, thereby enhancing patient compliance and reduces adverse effects.Another advanced technology is Machine learning & AI.These can work by making application of large datasets, advanced computing, and cloud storage, artificial intelligence-specifically, deep learning is automating attribute extraction and enhancemolecular design to speedup drug development. Nanotechnology has its importance in drug delivery, molecular imaging, and early illness diagnosis. In genome engineering, CRISPR/Cas9 technology is revolutionary because it offers targeted gene alteration for disease repair and advanced gene therapyas evidenced by recent approvals in the US and Europe. This review emphasizes not only the individual contributions of these technologies but also their potential intersections-for example, AI guided nanoparticle design or 3D printed drug delivery systems-that highlight their collective role in advancing personalized medicine. Together, these innovations provide novel solutions for drug discovery and therapy, with the potential to improve compliance, lower healthcare costs, reduce adverse reactions, and enhance accessibility to treatment.
Galanki et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: